Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes

NCT01342692 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

320

Enrollment

OTHER

Sponsor class

Conditions

MDS

Interventions

DRUG: Azacitidine
DRUG: Azacitidine associated with Valproic acid
DRUG: Azacitidine associated with Lenalidomide
DRUG: Azacitidine associated with Idarubicine

Sponsor

Assistance Publique - Hôpitaux de Paris